Profit Margin (Quarterly)

Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues

Intelligent Bio Solutions Inc. (INBS) had Profit Margin of -268.30% for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$1.11M
Net Income	$-2.98M
Cost of Goods Sold	$0.59M
Gross Profit	$0.52M
Operating Expenses	$4.11M
Operating Income	$-3.00M
Non-Operating Income/Expense	$0.00M
Pre-Tax Income	$-3.00M
Normalized Pre-Tax Income	$-3.00M
Income after Taxes	$-3.00M
Income from Continuous Operations	$-3.00M
Consolidated Net Income/Loss	$-3.00M
Normalized Income after Taxes	$-3.00M
EBIT	$-3.00M
EBITDA	$-2.74M
Weighted-Average Shares Outstanding (Basic)	8.55M
Weighted-Average Shares Outstanding (Diluted)	8.55M
Earnings per Share (EPS) (Basic)	$-0.35
Earnings per Share (EPS) (Diluted)	$-0.35
Balance Sheet Financials
Current Assets	$4.48M
Property, Plant, and Equipment	$0.27M
Long-Term Assets	$5.55M
Total Assets	$10.04M
Current Liabilities	$5.06M
Long-Term Debt	--
Long-Term Liabilities	$1.55M
Total Liabilities	$6.61M
Common Equity	$3.43M
Tangible Shareholders Equity	$-0.05M
Shareholders Equity	$3.43M
Common Shares Outstanding	9.10M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-2.85M
Cash Flow from Investing Activities	$-0.07M
Cash Flow from Financial Activities	$3.56M
Beginning Cash	$1.02M
End Cash	$1.66M
Increase/Decrease in Cash	$0.64M
Stock-Based Compensation	$0.01M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.89
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	0.04
Gross Margin	46.62%
Operating Margin	-269.80%
EBIT Margin	-269.80%
EBITDA Margin	--
Pre-Tax Profit Margin	-269.38%
Profit Margin	-268.30%
Free Cash Flow	$-2.85M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.11
Inventory Turnover	0.94
Receiveable Turnover	0.68
Days Sales in Receivables	132.91
Return on Equity	-87.40%
Return on Tangible Equity	6458.33%
Return on Assets	-29.84%
Return on Investments	-87.40%
Book Value Per Share	$0.38
Free Cash Flow per Share	$-0.33
Operating Cash Flow per Share	$-0.33

Data from Zacks Investment Research, Inc.